Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03179007 | CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 40 | Shanghai Cell Therapy Research InstituteOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT03171220 | Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors(NRT-01) | unknown | Phase 1 / Phase 2 | 40 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER |
| 1 |
| Jun 6, 2017 |
| clinicaltrials |
| NCT01910545 | Phase 1 Study of OTS167 in Patients With Solid Tumors | completed | Phase 1 | 32 | OncoTherapy Science, Inc.INDUSTRY | 1 | Jun 1, 2017 | clinicaltrials |
| NCT02086721 | Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor(L19-IL2) | completed | Phase 1 | 18 | Maastricht Radiation OncologyOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT01415297 | Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors | completed | Phase 1 | 46 | Niiki Pharma Inc.INDUSTRY | 1 | May 19, 2017 | clinicaltrials |
| NCT00954642 | A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 24 | Genentech, Inc.INDUSTRY | 0 | May 17, 2017 | clinicaltrials |
| NCT02490475 | A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors | completed | Phase 1 | 19 | Hoffmann-La RocheINDUSTRY | 2 | May 17, 2017 | clinicaltrials |
| NCT00972686 | Dose-Escalation Study of GSK2126458(FTIH) | completed | Phase 1 | 79 | GlaxoSmithKlineINDUSTRY | 2 | May 9, 2017 | clinicaltrials |
| NCT01031953 | Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy | terminated | Phase 1 / Phase 2 | 34 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00408499 | Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | University of California, DavisOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT01453387 | MSC2015103B in Solid Tumors | terminated | Phase 1 | 28 | EMD SeronoINDUSTRY | 1 | May 8, 2017 | clinicaltrials |
| NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | completed | Phase 1 | 74 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 4, 2017 | clinicaltrials |
| NCT01129349 | Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors | completed | Phase 1 | 44 | AmgenINDUSTRY | 1 | May 2, 2017 | clinicaltrials |
| NCT01577745 | A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors | completed | Phase 1 | 58 | MedImmune LLCINDUSTRY | 1 | May 2, 2017 | clinicaltrials |
| NCT01949545 | Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment | completed | Phase 1 | 46 | AmgenINDUSTRY | 4 | May 2, 2017 | clinicaltrials |
| NCT02274610 | Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer(DOPNP201) | completed | Phase 1 | 18 | Samyang Biopharmaceuticals CorporationINDUSTRY | 0 | May 1, 2017 | clinicaltrials |
| NCT00186979 | Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors | completed | Phase 1 | 34 | St. Jude Children's Research HospitalOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT01571024 | BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer | completed | Phase 1 | 17 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT00937417 | S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Apr 24, 2017 | clinicaltrials |
| NCT02567396 | Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 24, 2017 | clinicaltrials |
| NCT03117101 | Study of the AL3810 in the Treatment of Advanced Solid Tumor | completed | Phase 1 | 17 | Haihe Biopharma Co., Ltd.INDUSTRY | 1 | Apr 17, 2017 | clinicaltrials |
| NCT01359696 | A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 40 | Genentech, Inc.INDUSTRY | 2 | Apr 12, 2017 | clinicaltrials |
| NCT01940133 | A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309 | completed | Phase 1 | 28 | PIQUR Therapeutics AGINDUSTRY | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01957995 | Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 13 | University of Southern CaliforniaOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT01240590 | A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) | completed | Phase 1 / Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2017 | clinicaltrials |
| NCT02040558 | Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors | terminated | Phase 1 | 44 | MallinckrodtINDUSTRY | 1 | Apr 5, 2017 | clinicaltrials |
| NCT00519662 | Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors | completed | Phase 1 | 32 | Sunesis PharmaceuticalsINDUSTRY | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00731276 | Irinotecan in Treating Asian Patients With Solid Tumors | completed | Phase 1 | 18 | National Cancer Centre, SingaporeOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT01297452 | BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors | completed | Phase 1 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT01248949 | A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors | completed | Phase 1 | 162 | MedImmune LLCINDUSTRY | 1 | Mar 29, 2017 | clinicaltrials |
| NCT02379741 | ADC-1013 First-in-Human Study | completed | Phase 1 | 24 | Alligator Bioscience ABINDUSTRY | 3 | Mar 27, 2017 | clinicaltrials |
| NCT00878904 | Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors | completed | Phase 1 | 40 | University of California, San FranciscoOTHER | 1 | Mar 24, 2017 | clinicaltrials |
| NCT01537744 | A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma | completed | Phase 1 | 18 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 24, 2017 | clinicaltrials |
| NCT00662636 | Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 27 | Mayo ClinicOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT01516645 | Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors | terminated | Phase 1 | 14 | Kyowa Kirin Co., Ltd.INDUSTRY | 1 | Mar 16, 2017 | clinicaltrials |
| NCT00311597 | Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 48 | Wake Forest University Health SciencesOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT00551512 | Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid Tumors | completed | Phase 1 | 48 | CanBas Co. Ltd.INDUSTRY | 1 | Mar 14, 2017 | clinicaltrials |
| NCT01049841 | Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors | completed | Phase 1 | 23 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 10, 2017 | clinicaltrials |
| NCT01449370 | Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer | completed | Phase 1 | 125 | Millennium Pharmaceuticals, Inc.INDUSTRY | 3 | Mar 9, 2017 | clinicaltrials |
| NCT01390818 | Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 146 | EMD SeronoINDUSTRY | 3 | Mar 7, 2017 | clinicaltrials |
| NCT02216669 | Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer | withdrawn | Phase 1 | 0 | Maastricht Radiation OncologyOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT03062982 | Food-Effect and Metabolism Study in Healthy Subjects | completed | Phase 1 | 16 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Feb 24, 2017 | clinicaltrials |
| NCT01299701 | A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors | terminated | Phase 1 | 7 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 14, 2017 | clinicaltrials |
| NCT01504490 | Phase I Study of CS-7017 and Bexarotene | terminated | Phase 1 | 9 | Georgetown UniversityOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT02262455 | Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors | completed | Phase 1 | 32 | Santa Maria BiotherapeuticsINDUSTRY | 1 | Feb 13, 2017 | clinicaltrials |
| NCT02890511 | A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer | completed | Phase 1 / Phase 2 | 28 | Daehwa Pharmaceutical Co., Ltd.INDUSTRY | 1 | Feb 13, 2017 | clinicaltrials |
| NCT01489826 | A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours | completed | Phase 1 | 40 | e-Therapeutics PLCINDUSTRY | 1 | Feb 9, 2017 | clinicaltrials |
| NCT00861419 | To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib. | completed | Phase 1 | 88 | AmgenINDUSTRY | 0 | Feb 8, 2017 | clinicaltrials |
| NCT02048709 | Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors | completed | Phase 1 | 22 | Genentech, Inc.INDUSTRY | 1 | Feb 6, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Jun 7, 2017source: clinicaltrials